Tobin Juvenal
Corporate Officer/Principal at CASTLE BIOSCIENCES, INC.
Net worth: 982 504 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Derek Maetzold | M | 62 | 17 years | |
| Daniel Bradbury | M | 62 | 12 years | |
| G. Cole | M | 68 | 6 years | |
| Tiffany Olson | F | 64 | 3 years | |
| Kristen Oelschlager | F | 56 | 16 years | |
| Kimberlee Caple | F | 62 | 3 years | |
| Robert W. Cook | M | 52 | 13 years | |
| Ellen Goldberg | F | 50 | 3 years | |
| Miles Harrison | M | 59 | 4 years | |
| Camilla Zuckero | F | - | 5 years | |
| John Abbott | M | - | 10 years | |
| Kevin Doman | M | - | 2 years | |
| Chris Otte | M | - | - | |
| Keli Greenberg | F | - | 4 years | |
| John C. Cheneval | M | - | 3 years | |
| Noreen Manning | F | - | - | |
| Matthew Goldberg | M | - | 4 years | |
| Alice Bahner Izzo | F | - | 11 years | |
| Franklin Stokes | M | 54 | 7 years | |
| Johnson Clare | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 years |
| David Kabakoff | M | 76 | - | |
| Bernhard E. Spiess | M | 64 | 5 years | |
| Patrick Hall | M | - | - | |
| Joseph Cook | M | 53 | 3 years | |
| Mara Aspinall | F | 61 | 9 years | |
| Bonnie Anderson | F | 66 | 5 years | |
| Paul S. Manierre | M | 70 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 years |
| Garheng Kong | M | 49 | 3 years | |
| Frank Charles Carlucci | M | 91 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| William Ringo | M | 78 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 years |
| Carl Sterritt | M | 55 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| Timothy Decker | M | - | - | |
| Federico A. Monzon | M | 56 | 5 years | |
| James L. Dunn | M | 62 | 2 years | |
| Elizabeth Ann Fagan | M | 74 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 2 years |
| Acosta Greg | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tobin Juvenal
- Personal Network